PapersFlow Research Brief
Neonatal Health and Biochemistry
Research Guide
What is Neonatal Health and Biochemistry?
Neonatal Health and Biochemistry is the study of biochemical processes, genetic factors, and management strategies for hyperbilirubinemia and related conditions in newborn infants, including bilirubin metabolism, neonatal jaundice, kernicterus, phototherapy, and newborn screening programs.
This field encompasses 63,388 papers on topics such as glucose-6-phosphate dehydrogenase deficiency, UGT1A1 gene mutations, neurotoxicity, and bilirubin measurement methods. Key research demonstrates bilirubin's role as an antioxidant at micromolar concentrations that scavenges peroxyl radicals, challenging its view as solely cytotoxic. Management guidelines emphasize monitoring newborns to prevent severe hyperbilirubinemia and kernicterus.
Topic Hierarchy
Research Sub-Topics
Neonatal Hyperbilirubinemia Management
This sub-topic covers clinical guidelines, risk assessment nomograms, and therapeutic interventions for managing elevated bilirubin levels in newborns. Researchers study thresholds for phototherapy initiation, exchange transfusion criteria, and long-term outcomes of treatment protocols.
Glucose-6-Phosphate Dehydrogenase Deficiency
This sub-topic examines the genetic basis, hemolytic mechanisms, and hyperbilirubinemia risks in G6PD-deficient neonates. Researchers investigate screening methods, prevalence in populations, and triggers like oxidative stress leading to jaundice.
Bilirubin Metabolism Pathways
This sub-topic focuses on hepatic uptake, conjugation, and excretion processes of bilirubin in neonates. Researchers analyze enzyme kinetics, transporter proteins, and maturational delays contributing to physiologic jaundice.
Kernicterus and Bilirubin Neurotoxicity
This sub-topic explores bilirubin-induced brain injury mechanisms, selective neuronal vulnerability, and biomarkers of neurotoxicity. Researchers study animal models, histopathological changes, and long-term neurological sequelae.
UGT1A1 Gene Mutations
This sub-topic investigates UGT1A1 polymorphisms, Gilbert syndrome inheritance, and their role in prolonged neonatal jaundice. Researchers perform genotype-phenotype correlations and pharmacogenomic impacts on bilirubin clearance.
Why It Matters
Neonatal Health and Biochemistry guides clinical practices to prevent bilirubin-induced brain damage in newborns. The Subcommittee on Hyperbilirubinemia (2004) provides protocols for infants 35 or more weeks gestation, recommending monitoring and phototherapy to avoid kernicterus, with jaundice affecting most newborns but severe cases rare. "Bilirubin Is an Antioxidant of Possible Physiological Importance" by Stocker et al. (1987) reveals bilirubin's protective effects against oxidative stress in premature neonates, as expanded by Miller et al. (1993)'s antioxidant capacity assay applied to neonates, enabling better assessment of oxidative risk. Newborn screening, exemplified by Guthrie and Susi (1963)'s phenylalanine method detecting phenylketonuria in 682 infants, underscores early detection's role in averting neurological disorders.
Reading Guide
Where to Start
"Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation" by Subcommittee on Hyperbilirubinemia (2004), as it offers practical clinical guidelines on monitoring and intervention for jaundice, central to neonatal care.
Key Papers Explained
"Bilirubin Is an Antioxidant of Possible Physiological Importance" by Stocker et al. (1987) establishes bilirubin's protective radical-scavenging role, foundational for understanding its dual nature. Miller et al. (1993) in "A Novel Method for Measuring Antioxidant Capacity and its Application to Monitoring the Antioxidant Status in Premature Neonates" builds on this by providing a quantifiable assay for neonatal antioxidant status. Ryter et al. (2006) in "Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications" connects heme catabolism to bilirubin production, linking basic biochemistry to therapeutic potentials. Subcommittee on Hyperbilirubinemia (2004) translates these into management protocols, while Guthrie and Susi (1963) exemplify screening applications.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Research emphasizes genetic variants like UGT1A1 mutations and glucose-6-phosphate dehydrogenase deficiency in hyperbilirubinemia, alongside bilirubin measurement and phototherapy refinements. With 63,388 works, focus persists on preventing kernicterus through newborn screening programs, though no recent preprints or news indicate ongoing refinements in neurotoxicity thresholds and antioxidant applications.
Papers at a Glance
Frequently Asked Questions
What is the physiological role of bilirubin in neonates?
Bilirubin acts as an antioxidant at micromolar concentrations, efficiently scavenging peroxyl radicals generated chemically in vitro. Stocker et al. (1987) in "Bilirubin Is an Antioxidant of Possible Physiological Importance" showed this property positions bilirubin as a potential endogenous protector against oxidative damage in newborns.
How is hyperbilirubinemia managed in newborns 35 weeks or more gestation?
Newborns require monitoring for jaundice to identify those at risk of severe hyperbilirubinemia and kernicterus. The Subcommittee on Hyperbilirubinemia (2004) in "Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation" outlines phototherapy and intervention thresholds based on age and bilirubin levels.
What method measures antioxidant status in premature neonates?
A novel assay uses the absorbance of the ABTS*+ radical cation to quantify total antioxidant capacity in body fluids. Miller et al. (1993) in "A Novel Method for Measuring Antioxidant Capacity and its Application to Monitoring the Antioxidant Status in Premature Neonates" applied this to centrifugal analyzers for neonatal monitoring.
Why is newborn screening important for metabolic disorders?
Screening detects elevations in blood phenylalanine for phenylketonuria in large infant populations rapidly and economically. Guthrie and Susi (1963) in "A SIMPLE PHENYLALANINE METHOD FOR DETECTING PHENYLKETONURIA IN LARGE POPULATIONS OF NEWBORN INFANTS" tested 682 infants, with 96% at 4 days old, finding normal levels.
What is the role of heme oxygenase in bilirubin production?
Heme oxygenase-1 catalyzes heme conversion to biliverdin and bilirubin, producing carbon monoxide and iron. Ryter et al. (2006) in "Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications" detail its inducible isozyme's cytoprotective functions beyond metabolism.
How does bilirubin relate to kernicterus?
Unconjugated bilirubin at high levels causes neurotoxicity leading to kernicterus. Management focuses on preventing acute bilirubin encephalopathy through early detection and phototherapy, as per Subcommittee on Hyperbilirubinemia (2004) guidelines.
Open Research Questions
- ? How do specific UGT1A1 gene mutations quantitatively contribute to hyperbilirubinemia risk in diverse neonatal populations?
- ? What thresholds of bilirubin neurotoxicity differentiate benign jaundice from kernicterus in preterm infants?
- ? Can phototherapy protocols be optimized using real-time bilirubin measurement methods to minimize side effects?
- ? How do genetic variants in glucose-6-phosphate dehydrogenase interact with bilirubin metabolism to predict severe neonatal jaundice?
- ? What role does endogenous bilirubin antioxidation play in mitigating oxidative stress during neonatal sepsis?
Recent Trends
The field maintains 63,388 papers with sustained focus on hyperbilirubinemia management, bilirubin metabolism, and genetic factors like UGT1A1 mutations, as no growth rate, recent preprints, or news coverage is available.
Highly cited works such as Stocker et al. with 3494 citations continue to anchor research on bilirubin's antioxidant properties.
1987Research Neonatal Health and Biochemistry with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Neonatal Health and Biochemistry with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers